KEEP Summary Figures S40. Am J Kidney Dis. 2012;59(3)(suppl 2):S40-S64

Transcription

1 211 Summary Figures S4 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

2 Definitions DATA ANALYSES DIABETES Self-reported diabetes, self reported diabetic retinopathy, receiving medication for diabetes, or elevated blood glucose (WHO); fasting blood sugar 126 mg/dl or nonfasting blood sugar 2 mg/dl, or A1c 7% (if available) SELF-REPORTED DIABETES Self-reported diabetes or self-reported diabetic retinopathy GLYCEMIC CONTROL Fasting blood sugar <126 mg/dl or non-fasting blood sugar <2 mg/dl, and A1c <7% (if available) HYPERTENSION Self reported history hypertension, receiving a medication for hypertension, or elevated blood pressure (JNC7): Diabetes or ; systolic 13 mmhg or diastolic 8 mmhg, otherwise systolic 14 mmhg or diastolic 9 mmhg SELF-REPORTED HYPERTENSION Self-reported hypertension BLOOD PRESSURE CONTROL Diabetes or : systolic <13 mmhg and diastolic <8 mmhg, otherwise systolic <14 mmhg and diastolic <9 mmhg HIGH CHOLESTEROL Self-reported high cholesterol or receiving medication for cholesterol, or cholesterol level >2 mg/dl SELF-REPORTED HIGH CHOLESTEROL Self-reported high cholesterol CHOLESTEROL CONTROL Total cholesterol levels of 2 mg/dl SELF-REPORTED CARDIOVASCULAR DISEASE Participant reports any of the following cardiac events: heart attack, bypass surgery, heart angioplasty, stroke, heart failure, abnormal heart rhythm, or PVD (only for version 2) MICROALBUMINURIA Albumin/creatinine ratio 3 mg/g CHRONIC KIDNEY DISEASE egfr <6 ml/min/1.73 m 2 or egfr 6 ml/min/1.73 m 2 and albumin-creatinine ratio (ACR) 3 mg/g. GFR estimated using the IDMS-traceable 4-variable Modification of Diet in Renal Disease (MDRD) Study equation or Chronic Kidney Disease Epidemiology Collaboration equation (-EPI) for calibrated serum creatinine (Scr) values STAGES Stage 1: egfr 9 ml/min/1.73 m 2, and ACR 3 mg/g Stage 2: egfr 6 89 ml/min/1.73 m 2, and ACR 3 mg/g Stage 3: egfr 3 59 ml/min/1.73 m 2 Stage 4: egfr ml/min/1.73 m 2 Stage 5: egfr <15 ml/min/1.73 m 2 ANEMIA WHO Male: hemoglobin <13 g/dl Female: <12g/dl KDOQI (26) Males: hemoglobin <13.5 g/dl Women <12g/dl BODY MASS INDEX CATEGORIES UW: underweight, BMI <18.5 N: normal, BMI OW: overweight, BMI OB: obese, BMI EOB: extremely obese, BMI 4 EDUCATIONAL STATUS GSL: Grade school or less SHS: Some high school HSG: High school graduate SC+: Some college, college graduate, post-graduate NHANES DATA ANALYSES SELF-REPORTED DIABETES To be classified as having self-reported diabetes, participants had to report being told by a doctor, at any time, that they had diabetes or sugar diabetes other than that related to pregnancy. Participants answering borderline to the question were classified as non-diabetic. SELF-REPORTED HYPERTENSION Self-reported hypertension was identified by an affirmative answer to the question: Have you ever been told by a doctor that you had hypertension, also called high blood pressure. SELF-REPORTED HIGH CHOLESTEROL Self-reported high cholesterol was identified by an affirmative answere to the question: Have you ever been told by a doctor or other health professional that your blood cholesterol level was high? SELF-REPORTED CARDIOVASCULAR DISEASE Participant reports any of the following cardiac events: coronary heart disease, angina/angina pectoris, heart attack, congestive heart failure, or stroke. MICROALBUMINURIA Albumin/creatinine ratio 3 mg/g CHRONIC KIDNEY DISEASE egfr <6 ml/min/1.73 m 2 or egfr 6 ml/min/1.73 m 2 and albumin-creatinine ratio (ACR) 3 mg/g. GFR estimated using the IDMS-traceable 4-variable Modification of Diet in Renal Disease (MDRD) Study equation or Chronic Kidney Disease Epidemiology Collaboration equation (-EPI) for calibrated serum creatinine (Scr) values STAGES Stage 1: egfr 9 ml/min/1.73 m 2, and ACR 3 mg/g Stage 2: egfr 6 89 ml/min/1.73 m 2, and ACR 3 mg/g Stage 3: egfr 3 59 ml/min/1.73 m 2 Stage 4: egfr ml/min/1.73 m 2 Stage 5: egfr <15 ml/min/1.73 m 2 ANEMIA WHO Male: hemoglobin <13 g/dl Female: <12g/dl KDOQI (26) Males: hemoglobin <13.5 g/dl Women <12g/dl BODY MASS INDEX CATEGORIES UW: underweight, BMI <18.5 N: normal, BMI OW: overweight, BMI OB: obese, BMI EOB: extremely obese, BMI 4 EDUCATIONAL STATUS GSL: Grade school or less HSG: High school graduate SC+: Some college, college graduate, post graduate Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S41

3 Program accessibility cumulative # of partic. (in 1,s) ,65 48 Cumulative # of affiliates s.1 Cumulative number of eligible participants & affiliates, by year (2 21), N = 138,65 s.2 Geographic variations in the percent of participants, by state (2 21), N = 138,65 Percent of participants ( 4.89) 1.85 to < to < to <.92 Below.38 (.13) South Carolina Florida Indiana Utah Greater New York Western Pennsylvania Mass./Rhode Isl./N. Hampshire/Vermont Virginia Louisiana East Tennessee Connecticut Kentucky North Carolina National Capital Area Georgia Arizona Minnesota North Texas Hawaii Ohio Percent of participants s.3 Twenty largest affiliates, by percentage of participants screened (rank order) (2 21), N = 95,813 S42 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

4 Program accessibility s.a Total eligible participants, by year (2 21), N = 138,65 Age All All (%) ,4 1,85 1,391 1, ,77 1, , ,491 1,977 2,393 2,939 3,984 3,685 2,87 3,4 2,697 2,135 27, ,97 2,651 3,422 4,69 6,438 6,592 5,59 6,113 5,949 4,824 48, ,52 2,29 2,382 3,328 4,769 5,111 4,968 5,562 5,575 4,663 39, > ,76 1,547 1,656 1,683 1,938 1,959 1,774 13, Missing Gender Male 1,959 2,57 2,944 4,142 5,879 5,684 5,27 5,85 5,547 4,464 44, Female 4,123 5,473 6,976 8,975 12,192 12,613 1,88 11,889 11,65 9,629 94, Missing Race White 2,284 3,14 4,31 5,793 9,28 9,8 8,131 9,261 8,738 7,251 66, Black 2,652 3,392 3,43 4,274 5,267 5,565 5,41 5,42 5,479 4,476 44, Native American , Asian , , , Pacific Islander Other ,629 1,647 1,256 1,123 1,37 1,78 1,255 11, Unknown/missing , Ethnicity Hispanic ,117 1,89 2,416 2,317 2,75 2,163 2,317 1,851 17, Non-Hispanic 5,464 7,332 8,85 11,228 15,713 15,984 13,944 15,531 14,882 12, , Education Level <12 years 948 1,277 1,42 2,2 2,83 2,782 2,469 2,454 2,353 1,758 2, years 1,585 2,192 2,591 3,491 4,611 4,462 4,19 4,531 4,527 3,73 35, >12 years 1,629 2,155 2,775 3,459 4,675 4,351 3,815 4,54 4,272 3,56 35, years 1,143 1,463 1,913 2,53 3,614 3,814 3,228 3,682 3,738 3,274 28, >16 years ,132 1,467 2,145 2,453 2,19 2,299 2,117 1,769 16, Missing , Health Insurance Status Yes 4,948 6,428 7,892 1,153 14,56 14,27 12,44 13,631 12,579 1,577 16, No 883 1,234 1,66 2,49 3,251 3,371 3,292 3,525 3,88 3,196 26, Missing , All 6,82 8,44 9,922 13,118 18,129 18,31 16,19 17,694 17,199 14,97 138,65 1 "." Zero values in this cell Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S43

5 Targeting high-risk populations % with self-reported diabetes NHANES 99-6 All s.4 Self-reported diabetes in & NHANES participants (2 21), N= 137,765 NHANES ( ), N= 22,66 5 s.5 participants with diabetes Percent with diabetes (2 21), N= 138,58 All White Black Oth Hisp NHisp Percent aware s.6 participants with diabetes who are aware of their condition (2 21), N= 43,314 All Percent treated s.7 participants with diabetes who receive medication for their condition (2 21), N= 43,314 All S44 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

6 Targeting high-risk populations Percent with glycemic control All s.8 Glycemic control in participants with diabetes (2 21), N= 43,314 Percent with glycemic control All s.9 Glycemic control in participants with diabetes who are being treated for their condition (2 21), N= 2,487 Percent with glycemic control All s.1 Glycemic control in participants with diabetes who are not being treated for their condition (2 21), N= 22,827 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S45

7 Targeting high-risk populations s.11 % with self-reported hypertension NHANES 99-6 All Self-reported hypertension in & NHANES participants (2 21), N= 136,922 NHANES ( ), N= 22,366 s.12 1 participants with hypertension Percent with hypertension (2 21), N= 138,588 All Percent aware s.13 participants with hypertension who are aware of their condition (2 21), N= 97,567 All Percent treated s.14 participants with hypertension who receive medication for their condition (2 21), N= 97,567 All S46 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

8 Targeting high-risk populations s.15 4 Blood pressure control in participants with hypertension Percent controlled (2 21), N= 97,567 All Percent controlled s.16 Blood pressure control in participants with hypertension who are being treated for their condition (2 21), N= 6,553 All Percent controlled s.17 Blood pressure control in participants with hypertension not being treated for their condition (2 21), N= 37,14 All Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S47

9 Targeting high-risk populations % with self-reported high chol NHANES 99-6 NHANES: age 2-3 All s.18 Self-reported high cholesterol in & NHANES participants (2 21), N= 69,463 NHANES ( ), N= 13,535 Percent with high cholesterol All s.19 participants with high cholesterol (2 21), N= 94,28 Percent aware s.2 participants with high cholesterol who are aware of their condition (2 21), N= 58,623 All Percent treated s.21 participants with high cholesterol who receive medication for their condition (2 21), N= 58,623 All S48 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

10 Targeting high-risk populations Percent controlled s.22 Cholesterol control in participants with high cholesterol (2 21), N= 58,623 All Percent controlled s.23 Cholesterol control in participants with high cholesterol who are being treated for their condition (2 21), N= 19,118 All Percent controlled s.24 Cholesterol control in participants with high cholesterol who are not being treated for their condition (2 21), N= 39,55 All Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S49

11 Targeting high-risk populations s.25 % with self-reported CVD Age 23. Gender Race/ethnicity Self-reported cardiovascular disease in participants (2 21), N= 135,582 All White Black Other Hisp OW: 33.1 NHANES 99-6 N: 21.4 UW:.9 OW: 33.6 EO: 8.9 N: 32.8 UW: 1.9 EOB: 5.1 s.26 Percent distribution of & NHANES participants, by BMI (2 21), N= 137,5 NHANES ( ), N= 2,567 OB: OB: 26.5 S5 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

12 Prevalence of 75 Age: MDRD Gender Race/ethnicity s.27 Prevalence of in & NHANES participants Percent with EPI 75 NHANES 99-6 (2 21), N= 124,41 NHANES ( ), N= 19, NHANES 99-6 All White Black Other Hisp Percent with microalbuminuria NHANES 99-6 All White Black Other Hisp s.28 Prevalence of microalbuminuria in & NHANES participants (2 21), N= 127,593 NHANES ( ), N= 2,573. Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S51

13 Prevalence of s.b Total eligible participants with, by stage: MDRD equation (2 21), N= 138,65 Stage 1 & Stage 2 & Non- Abnormal ACR Abnormal ACR Stage 3 Stages 4-5 Missing All Age , ,43 9, , , ,61 27, ,634 1,43 2,46 4, ,32 48, , ,174 9, ,28 39,889 >75 5, , ,521 Gender Male 29,64 1,52 2,158 6, ,628 44,21 Female 62,367 2,515 4,5 15, ,54 94,328 Missing Race White 43,417 1,65 2,911 14, ,713 66,899 Black 3,731 1,629 2,121 4, ,569 44,978 Native American 2, ,466 Asian 5, ,167 Pacific Islander Other 8, , ,357 Unknown/missing ,932 3,23 Ethnicity Hispanic 12, , ,56 17,476 Non-Hispanic 79,85 2,972 5,548 19,935 1,14 11, ,129 U.S. Census Region Northeast 22, ,526 5, ,63 32,928 Midwest 13, , ,989 2,7 South 42,78 1,725 2,84 9, ,435 64,53 West 13, , ,746 2,436 Missing U.S. Census Division New England 7, , ,666 11,497 Middle Atlantic 14, ,43 3, ,397 21,431 East North Central 8, , ,3 12,654 West North Central 4, , ,46 South Atlantic 22, ,444 4, ,279 33,696 East South Central 11, , ,369 16,617 West South Central 9, , ,787 14,19 Mountain 7, , ,96 Pacific 5, , ,53 Missing Smoking Yes 34,397 1,483 2,657 8, ,571 53,38 No 54,736 1,952 3,365 11, ,812 8,496 Missing 2, ,729 Education Level < 12 years 12, ,71 3, ,448 2, years 22, ,78 6, ,584 35,91 >12 years 23, ,516 5, ,664 35, years 2, ,146 3, ,647 28,399 >16 years 11, , ,526 16,951 Missing 1, ,91 Health Insurance Status Yes 69,623 2,366 4,791 18,275 1,31 1,789 16,875 No 19,388 1,59 1,21 2, ,762 26,782 Missing 2, ,94 Doctor Status Yes 79,143 2,967 5,563 2,72 1,15 11,841 12,736 No 11, ,928 15,165 Missing 1, ,74 All 91,971 3,567 6,28 21,381 1,234 14, ,65 "." Zero values in this cell S52 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

14 Prevalence of 3 2 MDRD NHANES 99-6 s.29 Prevalence of in & NHANES participants, by stage (2 21), N= 124,41 NHANES ( ), N= 19,553 1 Percent with 3 2 -EPI 23.7 NHANES All Stage 1 Stage 2 Stage 3 Stages 4-5 s MDRD NHANES 99-6 Prevalence of in & NHANES participants, by risk factor (2 21), N= 123,463 NHANES ( ), N= 19,354 Percent with EPI NHANES 99-6 All No /DM /HTN /DM/HTN /Other Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S53

15 Prevalence of s.c Total eligible participants with, by stage: -EPI equation (2 21), N= 138,65 Stage 1 & Stage 2 & Non- Abnormal ACR Abnormal ACR Stage 3 Stages 4-5 Missing All Age , ,439 9, ,958 1, ,676 27, ,85 1,843 1,87 3, ,164 48, , ,17 8, ,368 39,889 >75 5, , ,521 Gender Male 3,83 1,35 1,968 5, ,669 44,21 Female 64,614 3,313 3,53 12, ,76 94,328 Missing Race White 45,515 1,515 2,664 11, ,97 66,899 Black 3,859 1,947 1,827 4, ,57 44,978 Native American 2, ,466 Asian 5, ,167 Pcific Islander Other 8, ,357 Unknown/missing ,932 3,23 Ethnicity Hispanic 12, ,39 9 2,6 17,476 Non-Hispanic 82,264 3,851 4,951 16,935 1,223 11,95 121,129 U.S. Census Region Northeast 22,719 1,67 1,375 4, ,131 32,928 Midwest 14, , , 2,7 South 43,9 2,26 2,487 7, ,573 64,53 West 14, , ,79 2,436 Missing U.S. Census Division New England 7, , ,79 11,497 Middle Atlantic 15, , ,422 21,431 East North Central 8, , ,1 12,654 West North Central 5, , ,46 South Atlantic 22,574 1,13 1,261 4, ,365 33,696 East South Central 11, , ,385 16,617 West South Central 9, , ,823 14,19 Mountain 8, , ,96 Pacific 5, ,53 Missing Smoking Yes 35,415 1,96 2,365 7, ,68 53,38 No 56,369 2,556 2,96 9, ,96 8,496 Missing 2, ,729 Education Level <12 years 12, , ,477 2, years 23,649 1,211 1,565 5, ,653 35,91 >12 years 24,379 1,228 1,319 4, ,716 35, years 2, , ,717 28,399 >16 years 12, , ,563 16,951 Missing 1, ,91 Health Insurance Status Yes 71,769 3,57 4,327 15,612 1,114 1,996 16,875 No 19,899 1, , ,86 26,782 Missing 3, ,94 Doctor Status Yes 81,569 3,849 4,966 17,46 1,233 12,73 12,736 No 11, ,95 15,165 Missing 1, ,74 All 94,697 4,618 5,498 17,974 1,313 14,55 138,65 "." Zero values in this cell S54 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

16 as a disease multiplier s MDRD:, Age 41.4 No Gender Race/ethnicity Self-reported diabetes in & NHANES participants with or without (2 21), N= 122,453 NHANES ( ), N= 19, NHANES 99-6 Percent with self-reported diabetes * -EPI: No NHANES * All White Black Other Hisp Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S55

17 as a disease multiplier MDRD:, 73.9 NHANES No s.32 Self-reported hypertension in & NHANES participants with or without (2 21), N= 121,762 NHANES ( ),N= 19,36 Percent with self-reported hypertension EPI: NHANES No All White Black Other Hisp S56 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

18 as a disease multiplier MDRD:, NHANES 99-6 No s.33 Self-reported high cholesterol in & NHANES participants with or without (2 21), N= 66,279 NHANES (2 29), N= 11,781 Percent with self-reported high cholesterol EPI: NHANES 99-6 NHANES: age 2-3 No NHANES: age All White Black Other Hisp Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S57

19 as a disease multiplier MDRD: Age 34.2 No Gender Race/ethnicity s.34 Self-reported cardiovascular disease in KEEp participants with or without (2 21), N= 124, % with self-reported CVD EPI 33.1 No All White Black Other Hisp MDRD:, Age No Gender s.35 BMI 3 kg/m 2 in & NHANES participants with or without (2 21), N= 122,756 NHANES ( ), N=19, NHANES Percent with BMI>= 3kg/m EPI: No 2 8 NHANES All Male Female S58 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

20 as a disease multiplier % of participants with anemia MDRD: WHO anemia EPI 5.4 NHANES 99-6 NHANES 99-6 KDOQI anemia s.36 Anemia (WHO & KDOQI definitions) in & NHANES participants with or without (2 21), N= 122,461 NHANES ( ), N= 19, All No All No MDRD: WHO anemia NHANES 99-6 Male Female KDOQI anemia * s.37 Anemia (WHO & KDOQI definitions) in & NHANES participants (2 21), N= 122,461 NHANES ( ), MDRD, N= 19,533, -EPI, N=19, Percent of participants with anemia EPI : WHO anemia KODQI anemia Male Female * * * All No Stg 1 Stg 2 Stg 3 Stgs 4-5 All No Stg 1 Stg 2 Stg 3 Stgs 4-5 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S59

21 as a disease multiplier s.d Odds ratio (OR) of, by risk factor (2 21), N= 62,715 MDRD equation OR Low Upper P-value Age < < <.1 Male Race White 1. Black <.1 Native American Asian <.1 Other Hispanic <.1 Self-reported diabetes <.1 Self-reported hypertension <.1 Self-reported high cholestrol <.1 Cardiovascular disease < <.1 Anemia (WHO definition) <.1 Insurance EPI equation OR Low Upper P-value Age < < <.1 Male Race White 1. Black <.1 Native American Asian <.1 Other Hispanic <.1 Self-reported diabetes <.1 Self-reported hypertension <.1 Self-reported high cholestrol <.1 Cardiovascular disease < <.1 Anemia (WHO definition) <.1 Insurance S6 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

22 Education & insurance SC: 25.7 HSG: 26.3 CG: 2.8 GSL/SHS 14.8 PG: 12.4 NHANES 99-6 HSG: 26.1 GSL: 2.7 SC+: 53.2 s.38 Percent distribution of & NHANES participants, by educational status (2 21), N= 136,694 NHANES ( ), N= 22,553 Percent with insurance 1 Age NHANES Gender s.39 Insurance coverage in & NHANES participants (2 21), N= 138,597 NHANES ( ), N= 22,3 All Non- Medicare: 38.1 Mcare with other than Mcaid: 12.2 Medicare 11.6 Unknown or missing: 34.8 Mcare/Mcaid: 3.2 s.4 Percent distribution of types of insurance in participants reporting they have insurance (2 21), N= 138,65 Percent with insurance NHANES White Black Other Hispanic s.41 Insurance coverage in & NHANES participants (2 21), N= 1 35,574 race, N= 138,597 ethnicity NHANES ( ), N= 22,3 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S61

23 RRT & mortality outcomes s.e Hazard ratio of RRT, controlled by risk factors (2 21), N= 11,423 s.f Hazard ratio of death, controlled by risk factors (2 21), N= 11,417 Estimate SE P-value Hazard ratio Age < <.1.34 Male.64.9 < Race White 1. Black < Native American Asian Other Hispanic Self-reported diabetes.48.1 < Self-reported hypertension Cardiovascular disease BMI 3 kg/m Anemia (WHO definition).92.1 < Insurance egfr(continuous) -.9. <.1.92 ACR 3mg/g < MDRD Study Equation Estimate SE P-value Hazard ratio Age < < < Male.56.3 < Race White 1. Black Native American.37.7 < Asian <.1.69 Other Hispanic Self-reported diabetes.34.4 < Self-reported hypertension Cardiovascular disease.51.4 < BMI 3 kg/m Anemia (WHO definition).57.4 < Insurance by MDRD non- 1. stage < stage < stage < EPI Equation Estimate SE P-value Hazard ratio Age < < < Male.55.3 < Race White 1. Black Native American.36.7 < Asian <.1.69 Other Hispanic Self-reported diabetes.34.4 < Self-reported hypertension Cardiovascular disease.51.4 < BMI 3 kg/m 2.94 Anemia (WHO definition).6. < Insurance by -EPI non- 1. stage < stage < stage < S62 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64

24 RRT & mortality outcomes Rate per 1, person years All White Black Other Hisp s.42 Rates of renal replacement therapy (RRT) in participants (2 21), N= 119,718 Rate per 1, person years MDRD equation Stage 1 Stage 2 Stages 3-5 -EPI equation Stage 1 Stage 2 Stages 3-5 Rate per 1, person years All White Black Other Hisp s.43 Mortality rates in participants (2 21), N= 122,641 Rate per 1, patient years MDRD equation Stage 1 Stage 2 Stages 3-5 -EPI equation Stage 1 Stage 2 Stages 3-5 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64 S63

25 Access, follow-up & intervention Percent with a physician Age 88.2 Gender Race/ethnicity s.44 participants with a physician (2 21), N= 135,91 All WhiteBlackOther Hisp NHisp % completing followup form s.45 follow-up response rate (%) (2 21), N=138,68 Reasons for seeing a physician (%) BP Glucose Urine egfr Hgb Cholesterol Other s.46 Reasons for seeing a physician in participants who return their follow-up forms (2 21), N= 35,275 S64 Am J Kidney Dis. 212;59(3)(suppl 2):S4-S64